HemoslL AcuStar HIT-lgG — Class I medical device recall Z-0002-2027
Ongoing recall by Instrumentation Laboratory, reported 2026-10-21, distributed nationwide. Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.
| Recall number | Z-0002-2027 |
|---|---|
| Product type | Medical device |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Instrumentation Laboratory, Bedford, MA, United States |
| Recall initiated | 2026-09-03 |
| Classified | 2026-10-09 |
| Reported by FDA | 2026-10-21 |
| Distributed | Nationwide (US) |
| Countries outside the US | AT, BE, CH, CR, CZ, DE, DK, ES, FI, FR, GB, GR, IN, IT, JO, JP, KR, LU, LV, NL, SA, SE, SG |
| Quantity | 1,414 units |
| UPC / GTIN / UDI-DI | 08426950545774 |
| Lot numbers | B38063, B40006 |
| Model numbers | 0009802028 |
Product
HemoslL AcuStar HIT-lgG(PF-4). Part Number: 0009802028. in vitro diagnostic (OUS only)
Reason for recall
Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0002-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-27. Not affiliated with or endorsed by FDA. Not medical or legal advice.